References
- Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM. 2020. Uterine Neoplasms, Version 1. 2020: Clinical Practice Guidelines in Oncology. https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf.
- Armbruster SD, Previs R, Soliman PT, Westin SN, Fellman B, Jhingran A, et al. 2019. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience. Gynecologic Oncology 154:328–332.
- Baba A, Yamazoe S, Dogru M, Ogawa M, Takamatsu K, Miyauchi J. 2016. Clear cell adenocarcinoma arising from adenomyotic cyst: a case report and literature review. The Journal of Obstetrics and Gynaecology Research 42:217–223.
- Colman H, Rosenthal A. 1959. Carcinoma developing in areas of adenomyosis. Obstetrics and Gynecology 14:342–348.
- Habiba M, Pluchino N, Petignat P, Bianchi P, Brosens IA, Benagiano G. 2018. Adenomyosis and Endometrial Cancer: Literature Review. Gynecologic and Obstetric Investigation 83:313–328.
- Koshiyama M, Suzuki A, Ozawa M, Fujita K, Sakakibara A, Kawamura M, et al. 2002. Adenocarcinomas arising from uterine adenomyosis: a report of four cases. International Journal of Gynecological Pathology: official Journal of the International Society of Gynecological Pathologists 21:239–245.
- Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, et al. 2012. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. The Lancet Oncology 13:385–394.
- Struble J, Reid S, Bedaiwy MA. 2016. Adenomyosis: a clinical review of a challenging gynecologic condition. Journal of Minimally Invasive Gynecology 23:164–185.
- Xiao W, Awadallah A, Xin W. 2012. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma. International Journal of Clinical and Experimental Pathology 5:642–650.